N/A N=206 Randomized Triple-blind Treatment

Targeting Attention Orienting to Social Threat to Reduce Social Anxiety in Youth

Social Anxiety Disorder of Childhood

Bottom Line

View on ClinicalTrials.gov: NCT03932032 ↗

Enrolled (actual)

206

Serious AEs

0.0%

Results posted

Apr 2026

Primary outcome: Primary: P1 Amplitude Elicited in the Dot-probe Task — 7.04; 5.61 microvolts

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Attention Bias Modification Treatment (Behavioral); Neutral Control Task (Behavioral)
Age: Pediatric · 10+ yrs
Sex: All
Sponsor: Florida International University
Primary completion: Jan 2026

Outcome Measures

Outcome	Result	p-value
PRIMARY P1 Amplitude Elicited in the Dot-probe Task	5.64; 4.98	—
PRIMARY P1 Amplitude Elicited in the Dot-probe Task	5.64; 4.98	—
SECONDARY Liebowitz Social Anxiety Scale for Children and Adolescents	74.76; 76.06	—
SECONDARY Liebowitz Social Anxiety Scale for Children and Adolescents	74.76; 76.06	—
SECONDARY Screen for Child Anxiety Related Emotional Disorders - Parent Version at Posttreatment	28.73; 27.69	—
SECONDARY Screen for Child Anxiety Related Emotional Disorders - Parent Version at Follow up	24.82; 22.43	—
SECONDARY Screen for Child Anxiety Related Emotional Disorders - Child Version at Posttreatment	31.89; 27.68	—
SECONDARY Screen for Child Anxiety Related Emotional Disorders - Child Version at Follow-Up	28.25; 20.79	—

Summary

This two-site study is a test of Attention Bias Modification Treatment (ABMT) among 260 youths ages 10 to 14 years with social anxiety disorder. One-half of participants will receive 8 sessions of computer administered ABMT and the other half of participants will receive 8 sessions of computer administered Neutral Control Task (NCT). The investigators hypothesize that a biomarker of attention to social threat measured using electroencephalography (EEG) and ratings of social anxiety severity will be lower in participants who receive ABMT compared to participants who receive NCT.

Eligibility Criteria

Inclusion Criteria

Be between ages 10 and 14 years
meet DSM5 criteria for a diagnosis of Social Anxiety Disorder
presence of any coexisting psychiatric diagnoses must be of lesser severity than Social Anxiety Disorder
have no current psychotropic medication other than a stable dose of stimulant or non-stimulant medication for coexisting ADHD

Exclusion Criteria

meet DSM5 criteria for Autism Spectrum Disorder, Intellectual Disability, Bipolar Disorder, Tourette's Disorder, Psychotic Disorders, or Substance Use Disorders
show high likelihood of hurting self or others
be a victim of undisclosed abuse requiring investigation/ supervision by the Department of Social Services
have an uncorrected vision or physical disability that interferes with the ability to click a mouse button rapidly and repeatedly
have a history of neurological illness, including seizures/epilepsy, or head injury with loss of consciousness > 5 minutes

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03932032). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.